0001104659-24-097862.txt : 20240906 0001104659-24-097862.hdr.sgml : 20240906 20240906193113 ACCESSION NUMBER: 0001104659-24-097862 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240904 FILED AS OF DATE: 20240906 DATE AS OF CHANGE: 20240906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sherman Darren CENTRAL INDEX KEY: 0001723524 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39421 FILM NUMBER: 241285596 MAIL ADDRESS: STREET 1: C/O MOTUS GI HOLDINGS, INC. STREET 2: 1301 EAST BROWARD BLVD, 3RD FLOOR CITY: FT. LAUDERDALE STATE: FL ZIP: 33301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orchestra BioMed Holdings, Inc. CENTRAL INDEX KEY: 0001814114 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 BUSINESS PHONE: 646-343-9298 MAIL ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp 2 DATE OF NAME CHANGE: 20200603 4 1 tm2423573-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-09-04 0 0001814114 Orchestra BioMed Holdings, Inc. OBIO 0001723524 Sherman Darren C/O ORCHESTRA BIOMED HOLDINGS, INC. 150 UNION SQUARE DRIVE NEW HOPE PA 18938 1 1 0 0 See Remarks 0 Common Stock, par value $0.0001 per share ("Common Stock") 2024-09-04 4 S 0 6837 6.10 D 793275 D Common Stock 2024-09-05 4 S 0 6961 5.85 D 786314 D Common Stock 2024-09-06 4 S 0 6819 5.65 D 779495 D The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs. The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.19, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission (the "SEC"), the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.61 to $6.14, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.50 to $5.94, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote. President and Chief Operating Officer /s/ Andrew Taylor, Attorney-in-Fact 2024-09-06